Somalia

Reimbursed Care Access

Somalia maintains a national legal framework governing narcotics dating from Act No. 46 (1970) and operates counter‑narcotics and prosecutorial units that enforce restrictions; however, health-sector availability of some anesthetic drugs (notably ketamine) is established on national essential medicines lists for clinical use. There is no evidence of authorized marketing, national regulatory approval, or public reimbursement pathways for modern psychedelic medicines (psilocybin, MDMA, DMT, etc.), which remain subject to criminal/controlled‑substances regulation except where tightly controlled medical use (ketamine) is permitted. Enforcement capacity is supported by the Somali Attorney General’s narcotics unit and international partners (UNODC) rather than by an integrated national reimbursement system for novel psychiatric indications.